End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.56 USD | -1.31% |
|
-10.14% | 0.00% |
24/06 | Inhibrx Biosciences, Inc.(NasdaqGS:INBX) dropped from S&P Biotechnology Select Industry Index | CI |
30/05 | Inhibrx Biosciences, Inc.(NasdaqGS:INBX) added to S&P TMI Index | CI |
Sales 2022 | 13.15L 11Cr | Sales 2023 | 16.34L 14Cr | Capitalization | 20Cr 1.64TCr |
---|---|---|---|---|---|
Net income 2022 | -12Cr -959.4Cr | Net income 2023 | -16Cr -1.29TCr | EV / Sales 2022 * | - |
Net cash position 2022 * | - 0 | Net cash position 2023 * | - 0 | EV / Sales 2023 * | - |
P/E ratio 2022 * |
-
| P/E ratio 2023 * |
-
| Employees | 173 |
Yield 2022 * |
-
| Yield 2023 * |
-
| Free-Float | 0% |
1 day | -1.31% | ||
1 week | -10.14% | ||
Current month | -4.30% | ||
1 month | -16.55% |
![Extreme 13.33](/images/extremecours_fleche.png)
![Extreme 13.33](/images/extremecours_fleche.png)
![Extreme 12.95](/images/extremecours_fleche.png)
![Extreme 12.95](/images/extremecours_fleche.png)
![Extreme 12.95](/images/extremecours_fleche.png)
![Extreme 12.95](/images/extremecours_fleche.png)
![Extreme 12.95](/images/extremecours_fleche.png)
Date | Price | Change | Volume |
---|---|---|---|
02/24/02 | 13.56 | -1.31% | 173,880 |
01/24/01 | 13.74 | -3.03% | 239,286 |
28/24/28 | 14.17 | +0.78% | 823,828 |
27/24/27 | 14.06 | -3.83% | 267,516 |
26/24/26 | 14.62 | -3.11% | 161,704 |
End-of-day quote Nasdaq, July 02, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 20Cr | |
+2.88% | 9.4TCr | |
+6.58% | 4.16TCr | |
-13.73% | 3.33TCr | |
+77.12% | 2.88TCr | |
-16.12% | 1.56TCr | |
-8.20% | 1.33TCr | |
-12.49% | 1.15TCr | |
+162.44% | 1.01TCr | |
-54.92% | 909.28Cr |
- Stock Market
- Equities
- INBX Stock